Emergency department multimarker point-of-care testing reduces time to cardiac marker results without loss of diagnostic accuracy

Point of Care

Volumn 5, Issue 3, 2006, Pages 132-136

  Storrow, Alan B ^a,e   Lindsell, Christopher J ^b   Collins, Sean P ^b   Fermann, Greg J ^b   Blomkalns, Andra L ^b   Williams, Janet M ^c   Goldsmith, Barbara ^d   Gibler, W Brian ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d ST ELIZABETH'S MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bedside testing; Cardiac markers; Point of care testing

Indexed keywords

EID: 33748571488     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/01.poc.0000232334.13428.7a     Document Type: Article

References (43)

1. Hedges JR, Young GP, Henkel GF, et al. Early CK-MB elevations predict ischemic events in stable chest pain patients. Acad Emerg Med. 1994;1(1):9-16.
2. Hoekstra JW, Hedges JR, Gibler WB, et al. Emergency department CK-MB: a predictor of ischemic complications. National cooperative CK-MB project group. Acad Emerg Med. 1994; 1 (1):17-27.
3. Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 1997;337(23):1648-1653.
4. Hamm CW. Cardiac biomarkers for rapid evaluation of chest pain. Circulation. 2001;104(13):1454-1456.
5. Wu AH, Apple FS, Gibier WB, et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem. 1999;45(7):1104-1121.
6. Storrow AB, Gibier WB. The role of cardiac markers in the emergency department. Clin Chim Acta. 1999;284(2):187-196.
7. Gibier WB. Evaluation of chest pain in the emergency department. Ann Intern Med. 1995;123(4):315. author reply 7-8.
8. Gibier WB, Runyon JP, Levy RC, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med. 1995;25(1):1-8.
9. Gibier WB, Hoekstra JW, Weaver WD, et al. A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT). J Am Coll Cardiol. 2000;36(5): 1500-1506.
10. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002;106(14):1893-1900.
11. Roberts R, Fromm RE. Management of acute coronary syndromes based on risk stratification by biochemical markers: an idea whose time has come. Circulation. 1998;98(18):1831-1833.
12. Califf RM, Ohman EM. The diagnosis of acute myocardial infarction. Chest. 1992;101(4 suppl):106S-115S.
13. Collinson PO. The need for a point of care testing: an evidence-based appraisal. Scand J Clin Lab Invest Suppl. 1999;230:67-73.
14. McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation. 2001;104(13):1483-1488.
15. Caragher TE, Fernandez BB, Jacobs FL, et al. Evaluation of quantitative cardiac biomarker point-of-care testing in the emergency department. J Emerg Med. 2002;22(1): 1-7.
16. Azzazy HM, Christenson RH. Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing? Clin Biochem. 2002;35(1):13-27.
17. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1999;34(3):890-911.
18. Bhatt DL, Topol EJ. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. JAMA. 2000;284(12): 1549-1558.
19. Tardiff BE, Califf RM, Tcheng JE, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II investigators. Integrilin (eptifibatide) to minimize platelet aggregation and coronary thrombosis-II. J Am Coll Cardiol. 1999;33(1):88-96.
20. Agewall S. Evaluation of point-of-care test systems using the new definition of myocardial infarction. Clin Biochem. 2003;36(1):27-30.
21. Apple FS, Anderson FP, Collinson P, et al. Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction. Clin Chem. 2000;46(10): 1604-1609.
22. Muller-Bardorff M, Sylven C, Rasmanis G, et al. Evaluation of a point-of-care system for quantitative determination of troponin T and myoglobin. Clin Chem Lab Med. 2000;38(6):567-574.
23. Heeschen C, Goldmann BU, Moeller RH, et al. Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I. Clin Chem. 1998;44(9):1925-1930.
24. Antman EM, Grudzien C, Sacks DB. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA. 1995;273(16): 1279-1282.
25. Brogan GX Jr., Bock JL, McCuskey CF, et al. Evaluation of cardiac STATus CK-MB/myoglobin device for rapidly ruling out acute myocardial infarction. Clin Lab Med. 1997;17(4):655-668.
26. Collinson PO, Gerhardt W, Katus HA, et al. Multicentre evaluation of an immunological rapid test for the detection of troponin T in whole blood samples. Eur J Clin Chem Clin Biochem. 1996;34(7):591-598.
27. Apple FS, Christenson RH, Valdes R Jr. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. Clin Chem. 1999;45(2): 199-205.
28. Stubbs P, Collinson PO. Point-of-care testing: a cardiologist's view. Clin Chim Acta. 2001;311(1):57-61.
29. Altinier S, Zaninotto M, Mion M, et al. Point-of-care testing of cardiac markers: results from an experience in an emergency department. Clin Chim Acta. 2001 ;311(1):67-72.
30. Novis DA, Jones BA, Dale JC, et al. Biochemical markers of myocardial injury test turnaround time: a College of American Pathologists Q-Probes study of 7020 troponin and 4368 creatine kinase-MB determinations in 159 institutions. Arch Pathol Lab Med. 2004; 128(2):158-164.
31. Lee-Lewandrowski E, Corboy D, Lewandrowski K, et al. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Arch Pathol Lab Med. 2004; 127:456-460.
32. Newby LK, Storrow AB, Gibler WB, et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation. 2001;103(14):1832-1837.
33. Gomez MA, Anderson JL, Karagounis LA, et al. An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO).J Am Coll Cardiol. 1996;28(1):25-33.
34. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350(7):647-654.
35. Wu AH, Clive JM. Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain. Clin Chem. 1997;43(2):326-332.
36. Fermann GJ, Suyama J. Point of care testing in the emergency department. J Emerg Med. 2002;22(4):393-404.
37. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA investigators. N Engl J Med. 1996;335(18):1333-1341.
38. Ohman EM, Armstrong PW, White HD, et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII investigators. Global use of strategies to open occluded coronary arteries. Am J Cardiol. 1999;84(11): 1281-1286.
39. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335(18): 1342-1349.
40. Newby LK, Kaplan AL, Granger BB, et al. Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. Am J Cardiol. 2000;85(7):801-805.
41. Brogan GX Jr, Friedman S, McCuskey C, et al. Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department. Ann Emerg Med. 1994;24(4):665-671.
42. Lindahl B, Venge P, Wallentin L. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemical markers of acute coronary syndromes. Coron Artery Dis. 1995;6(4):321-328.
43. Roxin LE, Cullhed I, Groth T, et al. The value of serum myoglobin determinations in the early diagnosis of acute myocardial infarction. Acta Med Scand. 1984;215(5):417-425.